Clinical trial
A Study to Investigate the Feasibility of Administration of a Speech Battery and the Use of Speech-based Biomarkers for the Clinical Assessment of Common Neurodegenerative and Psychiatric Disorders in a Remote Setting.
NCT04939818 is registered in ClinicalTrials.gov with Novoic Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Investigate the Feasibility of Administration of a Speech Battery and the Use of Speech-based Biomarkers for the Clinical Assessment of Common Neurodegenerative and Psychiatric Disorders in a Remote Setting.
- Lead sponsor
- Novoic Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 14, 2021
- Completion date
- September 15, 2022
- Enrollment
- 172 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, amyotrophic lateral sclerosis, bipolar disorder, dementia with lewy bodies, dementia, vascular, frontotemporal dementia, major depressive disorder, mild cognitive impairment, motor neuron disease, parkinson disease, primary progressive aphasia